We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-10.83%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.13%
AUM
$1.55B
AUM Growth
-$222M
Cap. Flow
-$13.5M
Cap. Flow %
-0.87%
Top 10 Hldgs %
17.52%
Holding
929
New
38
Increased
323
Reduced
374
Closed
111

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.49M
2
KO icon
Coca-Cola
KO
+$4.72M
3
ESRX
Express Scripts Holding Company
ESRX
+$2.71M
4
PX
Praxair Inc
PX
+$2.45M
5
XOM icon
ExxonMobil
XOM
+$2.14M

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.3%
2 Healthcare 11.61%
3 Financials 11.56%
4 Technology 11.53%
5 Consumer Staples 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
1
Coca-Cola
KO
$380B
$38.8M 2.5%
819,151
-98,685
-11% -$4.72M
MSFT icon
2
Microsoft
MSFT
$3.67T
$38.3M 2.47%
377,514
+7,305
+2% +$783K
AAPL icon
3
Apple
AAPL
$4.61T
$32.1M 2.06%
813,240
-42,848
-5% -$2.08M
VEA icon
4
Vanguard FTSE Developed Markets ETF
VEA
$240B
$29.5M 1.9%
796,400
+94,713
+13% +$3.75M
JPM icon
5
JPMorgan Chase
JPM
$940B
$26.9M 1.73%
275,643
-9,630
-3% -$1.03M
VOO icon
6
Vanguard S&P 500 ETF
VOO
$1.05T
$22.2M 1.43%
96,629
+2,076
+2% +$514K
AGG icon
7
iShares Core US Aggregate Bond ETF
AGG
$138B
$22M 1.42%
206,977
+1,715
+0.8% +$180K
PFE icon
8
Pfizer
PFE
$158B
$21.9M 1.41%
529,965
-37,236
-7% -$1.55M
JNJ icon
9
Johnson & Johnson
JNJ
$649B
$20.4M 1.31%
158,114
+4,506
+3% +$629K
IEFA icon
10
iShares Core MSCI EAFE ETF
IEFA
$196B
$20M 1.29%
363,561
+15,141
+4% +$888K
MRK icon
11
Merck
MRK
$366B
$19.9M 1.28%
272,779
-77,743
-22% -$5.49M
PG icon
12
Procter & Gamble
PG
$338B
$19.8M 1.27%
215,206
+3,177
+1% +$284K
VZ icon
13
Verizon
VZ
$209B
$19.7M 1.26%
349,693
+5,525
+2% +$314K
HD icon
14
Home Depot
HD
$313B
$19.6M 1.26%
113,820
-339
-0.3% -$60.8K
CSCO icon
15
Cisco
CSCO
$430B
$19.4M 1.25%
448,831
+15,672
+4% +$717K
CVX icon
16
Chevron
CVX
$412B
$17.8M 1.14%
163,474
+3,747
+2% +$434K
VXF icon
17
Vanguard Extended Market ETF
VXF
$31.4B
$17.5M 1.13%
175,651
+19,829
+13% +$2.17M
XOM icon
18
ExxonMobil
XOM
$661B
$15.8M 1.01%
231,123
-27,296
-11% -$2.14M
V icon
19
Visa
V
$688B
$15.7M 1.01%
118,793
-469
-0.4% -$64.8K
T icon
20
AT&T
T
$175B
$15M 0.96%
694,590
-10,044
-1% -$234K
ABBV icon
21
AbbVie
ABBV
$440B
$14.9M 0.96%
161,150
+3,070
+2% +$270K
GOOG icon
22
Alphabet (Google) Class C
GOOG
$4.1T
$14.8M 0.95%
285,320
+10,400
+4% +$557K
UNH icon
23
UnitedHealth
UNH
$360B
$12.8M 0.82%
51,364
-3,585
-7% -$947K
MMM icon
24
3M
MMM
$86.4B
$12.8M 0.82%
80,278
-1,803
-2% -$299K
UNP icon
25
Union Pacific
UNP
$171B
$12.4M 0.8%
89,597
-3,150
-3% -$467K

Similar funds

Raymond James Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James Trust held 929 positions worth $1.55B, down 12% from $1.78B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James Trust's Q4 2018 filing shows 38 new, 323 increased, 374 reduced and 111 closed positions. Its largest new stake was iShares MSCI ACWI ETF: 66,263 shares worth $4.25M. The largest sale was Merck, an estimated $5.49M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James Trust's largest Q4 2018 buy was iShares MSCI ACWI ETF: 66,263 shares worth $4.25M.
  • Raymond James Trust added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $3.75M increase.
  • Raymond James Trust's biggest Q4 2018 reduction was Merck, cutting an estimated $5.49M.
  • Raymond James Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $2.71M.
  • Raymond James Trust's ten largest holdings make up 18% of its $1.55B portfolio in Q4 2018.
  • Raymond James Trust opened 38 new positions and closed 111 in Q4 2018.
  • Raymond James Trust's portfolio value fell 12% quarter-over-quarter to $1.55B.

Based on Raymond James Trust's 13F filing for Q4 2018, filed 29 Jan 2019.